Back
Open Access

Thromboembolic prevention after TAVI: antiplatelets or anticoagulants? - Conclusion

Session: Thromboembolic prevention after TAVI: antiplatelets or anticoagulants?
Topic: Non coronary cardiac interventions
Speaker: Professor S. Windecker (Bern, CH)
Event: ESC CONGRESS 2016

Congress Session

0

About the speaker

Professor Stephan Windecker

Bern University Hospital, Inselspital, Bern (Switzerland)
29 presentations
4 followers

4 more presentations in this session

Thromboembolic prevention after TAVI: antiplatelets or anticoagulants? Positioning of the topic

Speaker: Professor R. Mehran (New York, US)

Access
Slides
Video
0
Thumbnail

All we need are antiplatelet agents – PRO

Speaker: Doctor A. Colombo (Milan, IT)

Access
Slides
Video
0
Thumbnail

All we need are antiplatelet agents – CON

Speaker: Professor L. Soendergaard (Copenhagen, DK)

Access
Slides
Video
0
Thumbnail

All we need are antiplatelet agents – Discussion PRO/CONTRA.

Access
Video
0
Thumbnail

Access the full session

Thromboembolic prevention after TAVI: antiplatelets or anticoagulants?

Speakers: Professor S. Windecker, Professor R. Mehran, Doctor A. Colombo, Professor L. Soendergaard
Access
0
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

This platform is supported by

logo Novo Nordisk